Jeff Ajer
2014
In 2014, Jeff Ajer earned a total compensation of $2.7M as Executive Vice President, Chief Commercial Officer at BioMarin Pharmaceutical, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,500 |
|---|---|
| Option Awards | $1,311,744 |
| Salary | $417,674 |
| Stock Awards | $719,340 |
| Other | $16,043 |
| Total | $2,677,301 |
Ajer received $1.3M in option awards, accounting for 49% of the total pay in 2014.
Ajer also received $212.5K in non-equity incentive plan, $417.7K in salary, $719.3K in stock awards and $16K in other compensation.
Rankings
In 2014, Jeff Ajer's compensation ranked 3,383rd out of 13,032 executives tracked by ExecPay. In other words, Ajer earned more than 74.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,383 out of 13,032 | 74th |
Division Manufacturing | 1,196 out of 4,966 | 76th |
Major group Chemicals And Allied Products | 389 out of 1,686 | 77th |
Industry group Drugs | 303 out of 1,365 | 78th |
Industry Pharmaceutical Preparations | 246 out of 1,043 | 76th |
Source: SEC filing on April 25, 2017.
Ajer's colleagues
We found four more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2014.
2014
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2014
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2014
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2014
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019